Sundrug Co.,Ltd. (TYO:9989)
Japan flag Japan · Delayed Price · Currency is JPY
4,796.00
+41.00 (0.86%)
Aug 8, 2025, 3:30 PM JST

Sundrug Revenue

In the fiscal year ending March 31, 2025, Sundrug had annual revenue of 801.81B JPY with 6.66% growth. Sundrug had revenue of 198.22B in the quarter ending March 31, 2025, with 6.68% growth.

Revenue
801.81B
Revenue Growth
+6.66%
P/S Ratio
0.70
Revenue / Employee
112.22M
Employees
7,145
Market Cap
560.98B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2025801.81B50.03B6.66%
Mar 31, 2024751.78B61.32B8.88%
Mar 31, 2023690.46B41.73B6.43%
Mar 31, 2022648.73B14.42B2.27%
Mar 31, 2021634.31B16.54B2.68%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Chugai Pharmaceutical1,196.22B
Takeda Pharmaceutical Company4,480.25B
HOYA Corporation876.09B
Daiichi Sankyo Company1,924.68B
Otsuka Holdings2,401.70B
Terumo1,037.94B
Astellas Pharma1,944.99B
Shionogi &440.50B
Revenue Rankings